- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06432426
Virtual Exercise on Elderly Breast Cancer Survivors
The Effect of Virtual Exercise on Elderly Breast Cancer Survivors on Functionality, Muscular Strength, and Quality of Life Effecto-B):
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a randomized controlled study. It will be conducted at the Dr. Sotero del Río Assistance Complex, which receives Southeast Metropolitan Health Service patients. Participants: 60 women over 60yrs who completed their antineoplastic treatment at least two years ago will be recruited.
Functionality will be measured using the Short Physical Performance Battery (SPPB), which is specific for older individuals. Hydraulic Dynamometry (Jamar © hydraulic hand dynamometer) will evaluate isometric upper limb muscle strength. Quality of life shall be assessed using the EORTC QLQ C30 Quality of Life Questionnaire - with its EORTC QLQ-ELD14 module, validated in the Chilean population. Feasibility will be measured using recruitment rate (≥50%), retention rate (≥ 80%), adherence rate (75% of total sessions ≥14 sessions), and incidence of adverse events.
Candidates will be randomly assigned to either virtual reality or traditional exercise groups. Both training groups will involve supervised sessions twice a week for nine weeks. The traditional exercise group exercises will be for arms and legs, involving body weight and external weights. Meanwhile, the virtual reality group will follow a physical exercise protocol using the "Nintendo Wii Fit" console. After the 9th week, participants will be evaluated one month after completing the training program.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Karol Ramírez-Parada, PT
- Phone Number: 22 3541168
- Email: kramirezp@uc.cl
Study Locations
-
-
Puente Alto
-
Santiago, Puente Alto, Chile
- Recruiting
- Complejo Asistencial Dr. Sótero del Rio
-
Contact:
- Karol Ramírez-Parada
-
Sub-Investigator:
- Scarlet Muñoz
-
Principal Investigator:
- Karol Ramírez-Parada
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women between 60 and 80 years old.
- Diagnosis of primary breast carcinoma.
- Treated with at least two of the following treatments: surgery, radiotherapy, chemotherapy, hormone therapy, biological therapy.
- Minimum of 2 years and a maximum of 10 years after finishing treatments (surgery, chemotherapy, and radiotherapy).
- Being able to walk at least 4 meters independently or with a cane as assistive technology
Exclusion Criteria:
- Stage IV breast cancer.
- Previous cancer treatment for any type of cancer other than breast cancer (chemotherapy, radiotherapy, or endocrine therapy).
- Cognitive impairment measured by the abbreviated Mini-Mental State Examination with a score < 13 points.
- Medical contraindication to perform physical exercise.
- Self-reported of physical activity equivalent to the recent American College of Sports Medicine Exercise Guidelines for Cancer Patients and Survivors (150 min/week of moderate aerobic exercise and strength exercise twice a week).
- Body mass index < 18.5 kg/m2 or > 40 kg/m2.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual Reality Training Group
Participants will undergo a postural balance rehabilitation program, utilizing a probed protocol for the elderly population with virtual reality via the Nintendo Wii Fit® and its peripheral Balance Board system.
Supervised group sessions will be conducted twice a week for 9 weeks.
|
Participants will be given virtual reality games on Nintendo Wii Fit® and its peripheral Balance Board system.
This equipment offers safe and engaging training protocols.
Additionally, it ensures physical exercise in the three planes of movement (sagittal, frontal, and transverse) and with three difficulty levels, thus providing a linear progressive demand.
|
|
Active Comparator: Standard physical exercise Group
Participants will undergo a standardized physical exercise program based on a validated protocol designed for elderly breast cancer survivors
|
Participants will be submitted to a standard physical exercise program based on the ACSM guidelines.
Resistance training will involve exercises for arms and legs, using bodyweight self-loading and external weights.
Balance exercises will include the three planes of movement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the functionality
Time Frame: Baseline, week 9 and week 13
|
Functionality will be measured by the Short Physical Performance Battery (SPPB).
This battery is specific for older individuals and assess balance, walking speed, and lower extremity strength/endurance.
It is a tool with moderate to excellent validity and excellent test-retest reliability (ICC=0.91).
|
Baseline, week 9 and week 13
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in upper limb muscle strength
Time Frame: Baseline, week 9 and week 13
|
Upper body muscle strength will be assessed by manual grip strength measured with a hydraulic dynamometer (Jamar© hydraulic hand dynamometer) in kilograms.
It is considered the gold standard for quantitative and objective evaluation of isometric hand and forearm muscle strength.
|
Baseline, week 9 and week 13
|
|
Change in lower limb muscle strength
Time Frame: Baseline, week 9 and week 13
|
Lower body muscle strength will be measured using the 30-second Chair Stand Test.
It has excellent validity and reliability in older adults.
It is measured in the number of repetitions.
The number of times the person can stand up from the chair in 30 seconds is recorded.
|
Baseline, week 9 and week 13
|
|
Change in the quality of life score
Time Frame: Baseline, week 9 and week 13
|
Quality if life will be assessed with the QLQ C-30 questionnaire and the specific module QLQ-ELD14.
The questionnaire could be self-administered and is validated to assess health-related quality of life in breast cancer patients.
It has been validated in Spanish and in the Chilean population.
Better quality of life is defined by a higher score (0-100) for global health status or overall quality of life.
|
Baseline, week 9 and week 13
|
|
Feasibility assesment
Time Frame: Baseline, week 1-9 and week 13
|
It will be measured by the recruitment rate (>50%), retention rate (>80%), adherence rate (75% of total sessions >14 sessions), and the incidence of adverse effects.
The measurements will be reported together as feasibility
|
Baseline, week 1-9 and week 13
|
Collaborators and Investigators
Investigators
- Principal Investigator: Karol Ramírez-Parada, PT, Pontificia Universidad Catolica de Chile
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 38330628
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
-
University of WashingtonTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIcUnited States
Clinical Trials on Virtual reality training group
-
Riphah International UniversityCompleted
-
Riphah International UniversityCompleted
-
Riphah International UniversityCompletedVestibular RehabilitationPakistan
-
Inonu UniversityCompletedMultiple Sclerosis | Multiple Sclerosis Relapsing Remitting | Balance Impairment, Gait Disorders, Fatigue | Multiple Sclerosis BeningTurkey
-
Riphah International UniversityRecruitingExercise | Old Age | Vestibular Disorder | BalancePakistan
-
Esra DOĞAN YILMAZ, PhDCompletedVirtual Reality | Empathy | Physical Examination of the Thorax and Lungs | Emotional Awareness | Self-confidence in Clinical Decision Making and AnxietyTurkey
-
Baylor Research InstituteCompletedAcquired Brain Injury
-
Gazi UniversityCompleted
-
University of Sao Paulo General HospitalCompleted
-
Riphah International UniversityCompletedPostmenopausal OsteopeniaPakistan